Moderna, Inc. - 54 Year Dividend History | MRNA
Historical dividend payout and yield for Moderna, Inc. (MRNA) since 1971. The current TTM dividend payout for Moderna, Inc. (MRNA) as of February 21, 2025 is $0.00. The current dividend yield for Moderna, Inc. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$13.673B |
$3.236B |
|
Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
